Mononucleosis (infection) is an acute, self-limited Infectious disease caused by EBV (a contagious virus, Epstein-Barr) . The clinical features were fever, Laryngitis, Hepatosplenomegaly, abnormal blood lymphocyte, abnormal lymphocyte, positive hetero-agglutination test and anti-EBV antibody in Vivo after infection. Adolescents and young adults (12 to 40 years old) are more likely to be affected.
This report contains market size and forecasts of Mononucleosis Diagnostic in Global, including the following market information:
Global Mononucleosis Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Mononucleosis Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monospot Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mononucleosis Diagnostic include Abbott Laboratories, ELITechGroup, Beckman Coulter, Bio-Rad Laboratories, Cardinal Health, Immunostics, Meridian Bioscience, Quidel Corporation and Sekisui Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mononucleosis Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mononucleosis Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Mononucleosis Diagnostic Market Segment Percentages, by Type, 2021 (%)
Monospot Test
Complete Blood Count Test
Epstein Barr Virus (EBV) Antibody Test
Global Mononucleosis Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Mononucleosis Diagnostic Market Segment Percentages, by Application, 2021 (%)
Hospitals
Laboratories
Others
Global Mononucleosis Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Mononucleosis Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mononucleosis Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Mononucleosis Diagnostic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
ELITechGroup
Beckman Coulter
Bio-Rad Laboratories
Cardinal Health
Immunostics
Meridian Bioscience
Quidel Corporation
Sekisui Diagnostics
Thermo Fischer Scientific
Siemens
Biomerieux